Ketamine Low dOse Evaluation on morphine consumption in traumatic patient - RCAPHM19_0374

Assistance Publique Hopitaux De Marseille0 个研究点目标入组 140 人开始时间: 2024年7月5日最近更新: 2024年8月21日

试验速览

暂无简介。

•Male or female over 18, Trauma patient with at least 2 lesions in two different regions as defined by the ISS (injury severity score) (Head or neck, Face, Thorax, Abdomen and pelvic contents, Limbs or pelvic girdle, External (entire skin surface) or trauma patient with at least 2 orthopedic lesions in the AIS region limbs or pelvic girdle combining 2 different limbs or 1 limb and the pelvic girdle., Patient with at least two regional or orthopedic injuries classified as moderate to maximal, defined by an AIS (Abbreviated Injury Scale) > 1., Patient with signed informed consent, Patient entitled to or affiliated with a social security scheme.

•Patients with an indication for deep sedation (intracranial hypertension or acute respiratory distress syndrome)., Presence of a history of psychosis or drug addiction., Patients with a history of stroke of less than 3 months., Patients allergic to ketamine or its excipients., Patients allergic to sufentanil or paracetamol., Pregnant or breast-feeding women., Patients who do not understand French., Patients under guardianship, curatorship or legal protection., Patients in whom the infusion could not be started within the first 12 hours of initial management in the investigating department., Patients whose state of consciousness is incompatible with understanding the protocol., Patients with chronic, unbalanced hypertension., Patients with severe heart failure (defined as systolic ejection fraction < 30%)., Patients with a BMI > 35 kg/m² or a weight of over 120 kg., Patient with chronic analgesic use, defined as opioid derivatives used for more than one week for an intercurrent illness., Presence of a history of chronic pain., Presence of a history of epilepsy not controlled by background treatment.

发起方